EX-10.31



 Exhibit 10.31 
 ENERGY FOCUS, INC. 
 SECURITIES PURCHASE AGREEMENT 

February 27, 2012 







 TABLE OF CONTENTS 

 

					
	 ARTICLE 1: Definitions
	  	 	1	  
	 Section 1.1. Definitions
	  	 	1	  
		
	 ARTICLE 2: Purchase and Sale
	  	 	6	  
	 Section 2.1. Issuance of Securities at the Closing
	  	 	6	  
	 Section 2.2. Payment of Purchase Price
	  	 	6	  
	 Section 2.3. Delivery of Securities
	  	 	6	  
	 Section 2.4. Additional Closing Deliveries
	  	 	6	  
		
	 ARTICLE 3: Representations and Warranties
	  	 	7	  
	 Section 3.1. Representations and Warranties of the Company
	  	 	7	  
	 Section 3.1(a) Subsidiaries
	  	 	7	  
	 Section 3.1(b) Organization and Qualifications
	  	 	7	  
	 Section 3.1(c) Authorization; Enforcement
	  	 	7	  
	 Section 3.1(d) No Conflicts
	  	 	8	  
	 Section 3.1(e) Filings, Consents and Approvals
	  	 	8	  
	 Section 3.1(f) Issuance of Securities
	  	 	8	  
	 Section 3.1(g) Capitalization
	  	 	8	  
	 Section 3.1(h) SEC Reports; Financial Statements
	  	 	9	  
	 Section 3.1(i) Material Changes
	  	 	9	  
	 Section 3.1(j) Litigation and Investigations
	  	 	10	  
	 Section 3.1(k) Labor Relations
	  	 	10	  
	 Section 3.1(l) Compliance
	  	 	10	  
	 Section 3.1(m) Regulatory Permits
	  	 	10	  
	 Section 3.1(n) Title to Assets
	  	 	11	  
	 Section 3.1(o) Patents and Trademarks
	  	 	11	  
	 Section 3.1(p) Insurance
	  	 	11	  
	 Section 3.1(q) Transactions with Affiliates and Employees
	  	 	11	  
	 Section 3.1(r) Sarbanes-Oxley; Internal Accounting Controls
	  	 	12	  
	 Section 3.1(s) Certain Fees
	  	 	12	  
	 Section 3.1(t) Certain Registration Matters
	  	 	12	  
	 Section 3.1(u) Investment Company
	  	 	12	  
	 Section 3.1(v) No Additional Agreements
	  	 	12	  
	 Section 3.1(w) Full Disclosure
	  	 	12	  
	 Section 3.1(x) Environmental Matters
	  	 	13	  
	 Section 3.1(y) Taxes
	  	 	13	  
	 Section 3.1(z) ERISA
	  	 	13	  
	 Section 3.1(aa) Foreign Assets Control Regulations and Anti-Money Laundering
	  	 	14	  
	 Section 3.1(bb) Acknowledgment Regarding Investors’ Trading Activity
	  	 	14	  
	 Section 3.1(cc) Regulation M Compliance
	  	 	15	  
	 Section 3.1(dd) Form S-3 Eligibility
	  	 	15	  


  
 i 









					
	 Section 3.2. Representations and Warranties of Investor
	  	 	15	  
	 Section 3.2(a) Authority
	  	 	15	  
	 Section 3.2(b) Own Account
	  	 	15	  
	 Section 3.2(c) Investor Status
	  	 	15	  
	 Section 3.2(d) Access to Information
	  	 	15	  
	 Section 3.2(e) General Solicitation
	  	 	16	  
	 Section 3.2(f) Disclosure
	  	 	16	  
	 Section 3.2(g) Regulation M Compliance
	  	 	16	  
		
	 ARTICLE 4: Registration Rights
	  	 	16	  
	 Section 4.1. Shelf Registration
	  	 	16	  
	 Section 4.2. Registration Process
	  	 	19	  
	 Section 4.3. Obligations and Acknowledgment of Investors
	  	 	22	  
	 Section 4.4. Expenses of Registration
	  	 	22	  
	 Section 4.5. Accountant’s Letter
	  	 	23	  
	 Section 4.6. Indemnification and Contribution
	  	 	23	  
	 Section 4.6(a) Indemnification by the Company
	  	 	23	  
	 Section 4.6(b) Indemnification by Investors
	  	 	23	  
	 Section 4.6(c) Notice of Claims, etc.
	  	 	24	  
	 Section 4.6(d) Contribution
	  	 	25	  
	 Section 4.6(e) Limitation on Investors’ Obligations
	  	 	25	  
	 Section 4.6(f) Other Liabilities
	  	 	25	  
	 Section 4.7. Rule 144
	  	 	26	  
	 Section 4.8. Common Stock Issued Upon Stock Split, etc.
	  	 	26	  
	 Section 4.9. Tolling of Deadlines
	  	 	26	  
		
	 ARTICLE 5: Other Agreements of the Parties
	  	 	26	  
	 Section 5.1. Certificates; Legends
	  	 	26	  
	 Section 5.2. Integration
	  	 	27	  
	 Section 5.3. Securities Laws Disclosure; Publicity
	  	 	28	  
	 Section 5.4. Use of Proceeds
	  	 	28	  
	 Section 5.5. Right of First Refusal
	  	 	28	  
	 Section 5.5(a) Proposed Financing
	  	 	28	  
	 Section 5.5(b) Pre- Notice of Proposed Financing
	  	 	28	  
	 Section 5.5(c) Investment Terms
	  	 	29	  
	 Section 5.5(d) Financings
	  	 	29	  
	 Section 5.6. Equal Treatment of Investors
	  	 	29	  
	 Section 5.7. Prospectus Delivery Requirements
	  	 	29	  
	 Section 5.8. Reservation of Common Stock
	  	 	29	  
	 Section 5.9. Subsequent Equity Sales
	  	 	30	  
	 Section 5.10. Disclosure of Information
	  	 	30	  
	 Section 5.11. Furnishing of Information
	  	 	30	  
		
	 ARTICLE 6: Conditions Precedent to Closing
	  	 	30	  
	 Section 6.1. Conditions Precedent to the Obligations of the Investor to Purchase Securities
	  	 	30	  
	 Section 6.1(a) Representations and Warranties
	  	 	30	  


  
 ii 










					
	 Section 6.1(b) Performance
	  	 	30	  
	 Section 6.1(c) No Injunction
	  	 	30	  
	 Section 6.1(d) No Adverse Changes
	  	 	31	  
	 Section 6.1(e) Company Deliverables
	  	 	31	  
	 Section 6.2. Conditions Precedent to the Obligations of the Company to Sell Securities
	  	 	31	  
	 Section 6.2(a) Representations and Warranties
	  	 	31	  
	 Section 6.2(b) Performance
	  	 	31	  
	 Section 6.2(c) No Injunction
	  	 	31	  
	 Section 6.2(d) Purchase Price
	  	 	31	  
		
	 ARTICLE 7: Miscellaneous
	  	 	31	  
	 Section 7.1. Fees and Expenses
	  	 	31	  
	 Section 7.2. Entire Agreement
	  	 	31	  
	 Section 7.3. Notices
	  	 	32	  
	 Section 7.4. Amendments; Waivers; No Additional Consideration
	  	 	32	  
	 Section 7.5. Termination
	  	 	32	  
	 Section 7.6. Construction
	  	 	33	  
	 Section 7.7. Successors and Assigns
	  	 	33	  
	 Section 7.8. No Third-Party Beneficiaries
	  	 	33	  
	 Section 7.9. Governing Law
	  	 	33	  
	 Section 7.10. Survival
	  	 	33	  
	 Section 7.11. Execution
	  	 	34	  
	 Section 7.12. Severability
	  	 	34	  
	 Section 7.13. Replacement of Securities
	  	 	34	  
	 Section 7.14. Remedies
	  	 	34	  
	 Section 7.15. Independent Nature of Investors’ Obligations and Rights
	  	 	34	  
		
	 Signature Pages
	  	 	follow page 35	  

 EXHIBIT A — Purchasers 
 EXHIBIT B — Form of Warrant 
 EXHIBIT C — Form of Legal Opinion 

EXHIBIT D — Plan of Distribution 

  
 iii









 ENERGY FOCUS INC. 

Securities Purchase Agreement 
 This Securities Purchase Agreement (this “Agreement”) is dated as of February 27, 2012, by and among Energy Focus, Inc., a Delaware corporation (the “Company”), and
the parties listed on the signature page hereto (each an “Investor” and together the “Investors”). 
 WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(2) of the Securities Act (as defined below) and the Commission’s Rule 506 promulgated
thereunder, the Company desires to issue and sell to the Investor, and the Investor desires to purchase from the Company, certain securities of the Company, as more fully described in this Agreement. 

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the
receipt and adequacy of which are hereby acknowledged, the Company and the Investor agree as follows: 
 ARTICLE 1

 DEFINITIONS 
 Section 1.1. Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings indicated in this
Section 1.1: 
 “Action” means any action, suit, inquiry, notice of violation, proceeding (including any
partial proceeding such as a deposition) or investigation pending or threatened in writing against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative
agency, regulatory authority (federal, state, county, local or foreign), stock market, stock exchange or trading facility. 

“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled
by or is under common control with a Person, as such terms are used in and construed under the Commission’s Rule 144. 

“Board” means the Board of Directors of the Company. 

“Business Day” means any day except Saturday, Sunday and any day which is a federal legal holiday or a day on which
banking institutions in the City of New York are authorized or required by law or other governmental action to close. 

“Claim” has the meaning set forth in Section 4.6(c). 

“Closing” means the closing of the purchase and sale of Shares and a Warrant pursuant to Article 2. 

  
 1 








 “Closing Date” means the Business Day immediately following the date on
which all of the conditions set forth in Sections 6.1 and 6.2 hereof are satisfied, or such other date as the parties may agree. 
 “Commission” means the Securities and Exchange Commission. 

“Common Stock” means the common stock of the Company, par value $0.001 per share, and any securities into which such
common stock may hereafter be reclassified. 
 “Common Stock Equivalents” means any securities of the Company
or any Subsidiary which entitle the holder thereof to acquire Common Stock at any time, including without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exchangeable for,
or otherwise entitles the holder thereof to receive, Common Stock or other securities that entitle the holder to receive, directly or indirectly, Common Stock. 
 “Company Counsel” means Cowden & Humphrey Co. LPA. 

“Company Deliverables” has the meaning set forth in Section 2.4. 

“Company Stock Options” has the meaning set forth in Section 3.1(g). 

“Contingent Obligations” has the meaning set forth in Section 3.1(r). 

“Convertible Securities” has the meaning set forth in Section 3.1(g). 

“Delaware Courts” has the meaning set forth in Section 7.9. 

“Effective Date” means the date that any Registration Statement filed pursuant to Article 4 is first declared effective
by the Commission. 
 “Effectiveness Period” has the meaning set forth in Section 4.1(b). 

“Environmental Law” has the meaning set forth in Section 3.1(aa). 

“ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and the rules and regulations promulgated
thereunder. 
 “ERISA Affiliate” means any trade or business, whether or not incorporated, that together with
the Company would be deemed to be a single employer for purposes of Section 4001 of ERISA or Sections 414(b), (c), (m), (n) or (o) of the Internal Revenue Code of 1986, as amended. 

“Evaluation Period” has the meaning set forth in Section 3.1(r). 

“Event” has the meaning set forth in Section 4.1(d). 

“Event Date” has the meaning set forth in Section 4.1(d). 

  
 2 








 “Exchange Act” means the Securities Exchange Act of 1934, as amended.

 “Exempt Issuance” means the issuance by the Company (a) to employees, officers, directors of, and
consultants to, the Company of shares of Common Stock or options for the purchase of shares of Common Stock pursuant to stock option or long-term incentive plans approved by the Board, (b) of shares of Common Stock upon the exercise of Warrants
issued hereunder, (c) of shares of Common Stock upon conversion of shares of Series A Preferred Stock, (d) of shares of Common Stock upon exercise of Prior Warrants or conversion of Prior Convertible Securities, (e) of securities
issued pursuant to acquisitions, licensing agreements, or other strategic transactions, (f) of securities issued in connection with equipment leases, real property leases, loans, credit lines, guaranties or similar transactions approved by the
Board, (g) of securities issued in connection with join ventures or similar strategic relationships approved by the Board, (h) of securities in a merger, (i) of securities in a public offering registered under the Securities Act, or
(j) of shares of Common Stock under its March 17, 2010 Purchase Agreement with Lincoln Park Capital Fund LLC (“LPC”), as amended or restated, or under a similar arrangement with LPC on similar terms; provided that in the case of
securities issued pursuant clauses (e), (f), (g) and (h), the purpose of such issuance may not be primarily to obtain cash financing. 
 “Filing Date” means the date that is thirty (30) days after the Closing Date or, if required by Commission regulation or rule, the date that is thirty (30) days after the date
that the Company files with the Commission its annual report on Form 10-K for the fiscal year ended December 31, 2011. 

“Financial Statements” has the meaning set forth in Section 3.1(h). 

“Financing Notice” has the meaning set forth in Section 5.5(b). 

“GAAP” means generally accepted accounting principles as in effect as of the date hereof in the United States of
America; if the Company in the future should choose to, or be required to, follow International Financial Reporting Standards (“IFRS”), the term GAAP shall refer to IFRS as in effect at that time in the United States of America.

 “Governmental Authority” has the meaning set forth in Section 3.1(e). 

“Hazardous Substance” has the meaning set forth in Section 3.1(aa). 

“Indebtedness” has the meaning set forth in Section 3.1(r). 

“Indemnified Party” has the meaning set forth in Section 4.6(c). 

“Indemnified Person” has the meaning set forth in Section 4.6(a). 

“Indemnifying Party” has the meaning set forth in Section 4.6(c). 

“Intellectual Property Rights” has the meaning set forth in Section 3.1(o). 

  
 3 








 “Lien” means any lien, charge, encumbrance, security interest, right of
first refusal or other restrictions of any kind. 
 “Material Adverse Effect” means any of (i) a material
and adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material and adverse effect on the results of operations, assets, prospects, business or condition (financial or otherwise) of the Company and
the Subsidiaries, taken as a whole, or (iii) a material impairment of the Company’s ability to perform on a timely basis its obligations under any Transaction Document. 

“OFAC” has the meaning set forth in Section 3.1(aa). 

“Penalty Base” has the meaning set forth in Section 4.1(d). 

“Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint
venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. 
 “Per Unit Purchase Price” has the meaning set forth in Section 2.1. 
 “Placement Agent” has the meaning set forth in Section 3.1(s). 
 “Post-Effective Amendment” means a post-effective amendment to the Registration Statement. 
 “Post-Effective Amendment Filing Deadline” means the seventh Business Day after the Registration Statement ceases to be effective pursuant to applicable securities laws due to the passage
of time or the occurrence of an event requiring the Company to file a Post-Effective Amendment. 
 “Prior Convertible
Securities” has the meaning set forth in Section 3.1(g). 
 “Prior Warrants” has the meaning set
forth in Section 3.1(g). 
 “Proceeding” means an action, claim, suit, investigation or proceeding
(including, without limitation, an investigation or partial proceeding, such as a deposition), whether commenced or threatened. 

“Prospectus” has the meaning set forth in Section 4.3. 

“Proposed Financing” has the meaning set forth in Section 5.5(a). 

“Purchase Price” has the meaning set forth in Section 2.2. 

“Registrable Securities” means the Shares and the Warrant Shares; provided, however, that the Investor shall not be
required to exercise the Warrants in order to have the Warrant Shares included in any Registration Statement. 

  
 4 








 “Registration Period” means the period commencing on the date hereof and
ending on the date on which all of the Registrable Securities may be sold to the public without registration and without volume or manner restrictions under the Securities Act in reliance on Rule 144. 

“Registration Statement” means a registration statement filed on the appropriate Form with, and declared effective by,
the Commission under the Securities Act and covering the resale by the Investor of the Registrable Securities. 

“Requested Information” has the meaning set forth in Section 4.3(a). 

“Required Effectiveness Date” means the earlier of (i) the date that is 90 days after the Closing Date without SEC
review or 120 days in the event of an SEC review process, or, in the case of the registration of Cut Back Shares (as defined in Section 4.1(a)), 120 days after the Restriction Termination Date or (ii) seven (7) Business Days after
receipt by the Company from the Commission of notice of “no review” of the Registration Statement. 
 “Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as
such Rule. 
 “SEC Reports” has the meaning set forth in Section 3.1(h). 

“Securities” means the Shares, the Warrants, and the Warrant Shares. 

“Securities Act” means the Securities Act of 1933, as amended. 

“Shares” means the shares of Common Stock issuable to the Investor at the Closing. 

“Subsidiary” means any “significant subsidiary” as defined in Rule 1-02(w) of Regulation S X promulgated by
the Commission under the Exchange Act. 
 “Trading Day” means (i) a day on which the Common Stock is
traded on a Trading Market, or (ii) if the Common Stock is not listed on a Trading Market, a day on which the Common Stock is quoted on the over-the-counter market, as reported by the OTC Bulletin Board, or (iii) if the Common Stock is not
then listed on a Trading Market or quoted on the OTC Bulletin Board, a day on which the Common Stock is quoted in the over-the-counter market as reported by the Pink OTC Market Inc. or any similar organization or agency succeeding to its functions
of reporting prices; provided, that in the event that the Common Stock is not listed or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day shall mean a Business Day. 

“Trading Market” means whichever of the New York Stock Exchange or the NASDAQ Stock Market, Inc. on which the Common
Stock is listed or traded on the date in question. 
 “Transaction Documents” means this Agreement, the Warrant
and any other documents or agreements executed in connection with the transactions contemplated hereunder. 

“Unit” means a unit consisting of one Share and one-half (1/2) Warrant to purchase one share of Common Stock,
issued in combination. 

  
 5 








 “Warrant” means any of the Common Stock Purchase Warrants, in the form of
Exhibit B, which are issuable to the Investor at the Closings. 
 “Warrant Shares” means the shares of
Common Stock issuable upon exercise of the Warrants. 
 ARTICLE 2 

PURCHASE AND SALE 
 Section 2.1. Issuance of Securities at the Closing. Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with applicable law, the Company agrees to
sell to the Investors, and the Investors agree, severally and not jointly, to purchase from the Company, for a per Unit purchase price of $0.25 (the “Per Unit Purchase Price”), on the Closing Date, the number of Units opposite each
Investor’s name on Exhibit A attached hereto, each Unit to consist of (i) one (1) Share and (ii) one-half (1/2) Warrant to purchase one (1) share of Common Stock. 

Section 2.2. Payment of Purchase Price. As consideration for the issuance of the Securities being purchased at the Closing,
each Investor shall on the Closing Date pay to the Company, by wire transfer of immediately available funds, an amount equal to (i) the Per Unit Purchase Price multiplied by (ii) the number of Units opposite each Investor’s name on
Exhibit A attached hereto. The aggregate purchase price payable by all of the Investors hereunder is hereinafter referred to as the “Purchase Price.” 
 Section 2.3. Delivery of Securities. At the Closing, the Company shall, against payment by each Investor of its pro rata share of the Purchase Price, (i) issue to each Investor the
Warrants included in the Units being purchased at the Closing and (ii) execute and deliver to the transfer agent for the Common Stock irrevocable instructions to issue to each Investor the number of Shares included in the Units being purchased
at the Closing. 
 Section 2.4. Additional Closing Deliveries. At the Closing, the Company shall deliver or cause
to be delivered to each Investor the following (the “Company Deliverables”): 
 (i) The legal opinion of Company
Counsel, in substantially the form of Exhibit C hereto, addressed to each Investor; 
 (ii) The Certificate of
Incorporation of the Company, together with all amendments thereto, certified by the Secretary of State of the State of Delaware as of a recent date; 
 (iii) Copies of each of the following documents, in each case certified by the Secretary of the Company to be in full force and effect on the Closing Date: 

(A) resolutions of the board of directors of the Company approving the execution, delivery and performance of the Transaction Documents
and the transactions contemplated thereby; 
 (B) the Bylaws of the Company; and 

  
 6 








 (C) irrevocable instructions to the Company’s transfer agent as to the reservation and
issuance of the Warrant Shares; and 
 (iv) A good standing certificate of the Company issued by the Secretary of State of the
State of Delaware dated as of a recent date. 
 ARTICLE 3 

REPRESENTATIONS AND WARRANTIES 
 Section 3.1. Representations and Warranties of the Company. The Company hereby makes the following representations and warranties to each Investor: 

(a) Subsidiaries. The Company has no direct or indirect Subsidiaries other than as specified in the SEC Reports. Except as
disclosed in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock of each Subsidiary free and clear of any and all Liens other than Liens disclosed in the SEC Reports, and all the issued and outstanding shares of
capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights. 
 (b) Organization and Qualification. Each of the Company and each Subsidiary is duly incorporated or otherwise organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization (as applicable), with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in
violation of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and each Subsidiary is duly qualified to conduct its respective business and is
in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing,
as the case may be, could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, and no proceedings have been instituted in any such jurisdiction revoking, limiting or curtailing, or seeking to
revoke, such power and authority or qualification. 
 (c) Authorization; Enforcement. The Company has the
requisite corporate power and authority to enter into and to consummate the transactions contemplated by each of the Transaction Documents and otherwise to carry out its obligations thereunder. The execution and delivery of each of the Transaction
Documents by the Company and the consummation by it of the transactions contemplated thereby have been duly authorized by all necessary action on the part of the Company and no further corporate action is required by the Company in connection
therewith. Each Transaction Document has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof, will constitute the valid and binding obligation of the Company enforceable against
the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of,
creditors’ rights and remedies or by other equitable principles of general application. 

  
 7 








 (d) No Conflicts. The execution, delivery and performance of the Transaction
Documents by the Company and the consummation by the Company of the transactions contemplated thereby do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a breach or default (or an event that with notice or lapse of time or both would become a breach or default) under, or give to others any
rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, or result in the imposition of any Lien upon any of the material properties or assets of the Company or of any Subsidiary pursuant to,
any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any
Subsidiary is bound or affected, or (iii) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject
(including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not, individually or in
the aggregate, have or reasonably be expected to result in a Material Adverse Effect. 
 (e) Filings, Consents and
Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority (a
“Governmental Authority”) or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents and the consummation of the transactions contemplated thereby, other than (i) the
filing of a Notice of Sale of Securities on Form D with the Commission under Regulation D of the Securities Act (ii) filings required under applicable state securities laws, and (iii) the filing with the Commission of one or more
Registration Statements in accordance with the requirements of Article 4 of this Agreement,. 
 (f) Issuance of the
Securities. The Shares have been duly authorized and, when issued and paid for in accordance with this Agreement, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens, other than Liens created by the
Investors and those imposed by applicable securities laws. The Company has reserved and set aside from its duly authorized capital stock a sufficient number of shares of Common Stock to satisfy in full the Company’s obligations to issue the
Warrant Shares upon exercise of the Warrants. The Warrant Shares are duly authorized and, when issued and paid for upon exercise of the Warrants in accordance with their terms, will be duly and validly issued, fully paid and nonassessable, free and
clear of all Liens, other than Liens created by the Investors and those imposed by applicable securities laws. 
 (g)
Capitalization. The authorized capital stock of the Company consists of 60,000,000 shares of Common Stock, par value $0.0001 per share, and 2,000 shares of Preferred Stock, par value $0.0001 per share. As of the close of business on
January 31, 2012, (i) no shares of Preferred Stock were issued and outstanding, (ii) 24,913,135 shares of Common Stock were issued and outstanding, all of which are validly issued, fully-paid and non-assessable, (iii) 7,815,288
shares of Common Stock were reserved for issuance upon exercise of outstanding options granted to employees, directors, and consultants of the Company (the “Company Stock 

  
 8 








 
Options”), for issuance upon exercise of outstanding warrants to purchase Common Stock (the “Prior Warrants”), for issuance upon conversion of other convertible
notes, debentures or securities (“Prior Convertible Securities”), and for sale under our March 17, 2010 Purchase Agreement with Lincoln Park Capital Fund, LLC, and (iv) 27,271,577 shares of Common Stock were unreserved and
unissued. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except pursuant to (i) the Company Stock Options,
(ii) the Prior Warrants, or (iii) the Prior Convertible Securities, or as a result of the purchase and sale of the Securities as contemplated by this Agreement, there are no outstanding options, warrants, script rights to subscribe to,
calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock, or contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents. The issue and sale of the Securities will not obligate the Company to
issue shares of Common Stock or other securities to any Person other than the Investors and will not result in a right of any holder of Company securities to adjust the exercise or conversion price under such securities. No further approval or
authorization of any stockholder, the Board of Directors of the Company or any other Person is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to
the Company’s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company’s stockholders. 
 (h) SEC Reports; Financial Statements. The Company has filed all reports required to be filed by it under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or
15(d) thereof, for the twelve months preceding the date hereof (the foregoing materials, including reports on the SEC Form 8-K, being collectively referred to herein as the “SEC Reports”). As of their respective dates, the SEC
Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue
statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The financial statements
of the Company (the “Financial Statements”) included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the
time of filing. Such Financial Statements have been prepared in accordance with GAAP applied on a consistent basis during the periods involved, except as may be otherwise specified in such Financial Statements or the notes thereto, and fairly
present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited
statements, to normal year-end audit adjustments. 
 (i) Material Changes. Except as set forth in the Financial
Statements or SEC Reports, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities or obligations
(contingent or otherwise) other than (A) trade payables, accrued expenses and other liabilities incurred in the ordinary course of business consistent with past 

  
 9 








 
practice incurred since the date of the most recent Financial Statements and (B) liabilities incurred in the ordinary course of business not required to be reflected in the Financial
Statements pursuant to GAAP or required to be disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting or the identity of its auditors, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock, and (v) the Company has not issued any equity securities to any officer, director
or Affiliate, except pursuant to existing Company stock option plans or the Company Stock Options. The Company does not have pending before the Commission any request for confidential treatment of information. The Company maintains and will continue
to maintain a standard system of accounting established and administered in accordance with GAAP. 
 (j) Litigation and
Investigations. There is no Action which (i) challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) except as specifically disclosed in the SEC Reports, could, if there
were an unfavorable decision, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof (in his capacity as such), is the
subject of any pending Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty, except as specifically disclosed in the SEC Reports. To the knowledge of the Company, there
is not pending any investigation by the Commission involving the Company or any current or former director or officer of the Company (in his or her capacity as such). The Commission has not issued any stop order or other order suspending the
effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act. There are no outstanding comments by the staff of the Commission on any filing by the Company or any Subsidiary under
the Exchange Act or the Securities Act. 
 (k) Labor Relations. No material labor dispute exists or, to the
knowledge of the Company, is imminent with respect to any of the employees of the Company. 
 (l) Compliance.
Neither the Company nor any Subsidiary (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under),
nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of
its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any order of any court, arbitrator or governmental body, or (iii) is or has been in violation of any statute, rule or regulation of
any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in
each case as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. 
 (m) Regulatory Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory
authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such permits could not, individually or in the 

  
 10 









 aggregate, have or reasonably be expected to result in a Material Adverse Effect, and neither the Company
nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any such permits. 
 (n)
Title to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them that is material to their respective businesses and good and marketable title in all personal property
owned by them that is material to their respective businesses, in each case free and clear of all Liens, except for Liens that do not materially affect the value of such property and do not materially interfere with the use made and proposed to be
made of such property by the Company and the Subsidiaries, and except for Liens set forth in the Financial Statements or SEC Reports. All real property and facilities held under lease by the Company and the Subsidiaries are held by them under leases
of which the Company and the Subsidiaries are in material compliance, except as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. 

(o) Patents and Trademarks. The Company and the Subsidiaries have, or have valid rights to use, all patents, patent
applications, trademarks, trademark applications, service marks, trade names, copyrights, licenses and other similar rights that are necessary or material for use in connection with their respective businesses as described in the SEC Reports and
which the failure to so have could, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect (collectively, the “Intellectual Property Rights”). No claims or Actions have been made or
filed by any Person against the Company to the effect that Intellectual Property Rights used by the Company or any Subsidiary violate or infringe upon the rights of such claimant. To the knowledge of the Company, after commercially reasonable
investigation, all of the Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights or by the Company of the Intellectual Property Rights of any other Person.

 (p) Insurance. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as the Company believes are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged. The Company has no reason to believe that it will not be able to renew its
and the Subsidiaries’ existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business on terms consistent with the market for the Company’s and
such Subsidiaries’ respective lines of business. 
 (q) Transactions With Affiliates and Employees. Except as
set forth in the SEC Reports, none of the officers or directors of the Company and, to the knowledge of the Company, none of the employees of the Company is a party to any transaction with the Company or any Subsidiary (other than for services as
employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from
any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner. 

  
 11 









 (r) Sarbanes-Oxley; Internal Accounting Controls. The Company is in material
compliance with all provisions of the Sarbanes-Oxley Act of 2002 (including the rules and regulations of the Commission adopted thereunder) which are applicable to it as of the Closing Date. The Company’s certifying officers have evaluated the
effectiveness of the Company’s disclosure controls and procedures as of the filing date of the most recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”). The Company presented in its most
recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there
have been no significant changes in the Company’s internal controls (as such term is defined in Item 307(b) of Regulation S-K under the Exchange Act), or to the Company’s knowledge, in other factors that could significantly affect the
Company’s internal controls. 
 (s) Certain Fees. No brokerage or finder’s fees or commissions are or
will be payable by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by this Agreement. The Investors shall have no obligation
with respect to any fees or with respect to any claims (other than such fees or commissions owed by the Investors pursuant to written agreements executed by the Investors which fees or commissions shall be the sole responsibility of the Investors)
made by or on behalf of any Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by this Agreement. 
 (t) Certain Registration Matters. Assuming the accuracy of each Investor’s representations and warranties set forth in Section 3.2(b)-(e), no registration under the Securities Act
is required for the offer and sale of the Securities by the Company to the Investors under the Transaction Documents. 
 (u)
Investment Company. The Company is not, and is not an Affiliate of, and immediately following the Closing will not have become, an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

 (v) No Additional Agreements. The Company does not have any agreement or understanding with the Investors with
respect to the transactions contemplated by the Transaction Documents other than as specified in the Transaction Documents. 

(w) Full Disclosure. The SEC Reports and the Company’s representations and warranties set forth in this Agreement,
taken together, are true and correct in all material respects and do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances under
which they were made, not misleading. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided
any of the Investors or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Investors will rely on the foregoing representation
in effecting transactions in securities of the Company. The Company acknowledges and agrees that no Investor makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set
forth in Section 3.2 hereof. 

  
 12 









 (x) Environmental Matters. To the Company’s knowledge: (i) the
Company and its Subsidiaries have complied with all applicable Environmental Laws, except for such noncompliance as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect; (ii) after
commercially reasonable investigation, the properties currently owned or operated by Company (including soils, groundwater, surface water, buildings or other structures) are not contaminated with any Hazardous Substances; (iii) after
commercially reasonable investigation, the properties formerly owned or operated by Company or its Subsidiaries were not contaminated with Hazardous Substances during the period of ownership or operation by Company and its Subsidiaries;
(iv) Company and its Subsidiaries are not subject to any material liability for any Hazardous Substance disposal or contamination on any third party property; (v) Company and its Subsidiaries have not received any written notice, demand,
letter, claim or request for information alleging that Company and its Subsidiaries may be in violation of or liable under any Environmental Law; and (vi) Company and its Subsidiaries are not subject to any orders, decrees, injunctions or other
arrangements with any Governmental Authority or subject to any indemnity or other agreement with any third party relating to liability under any Environmental Law or relating to Hazardous Substances which could, individually or in the aggregate,
have or reasonably be expected to result in a Material Adverse Effect. 
 As used in this Agreement, the term
“Environmental Law” means any federal, state, local or foreign law, regulation, order, decree, permit, authorization, opinion, common law or agency requirement relating to: (A) the protection, investigation or restoration of
the environment, health and safety, or natural resources; (B) the handling, use, presence, disposal, release or threatened release of any Hazardous Substance or (C) noise, odor, wetlands, pollution, contamination or any injury or threat of
injury to persons or property. 
 As used in this Agreement, the term “Hazardous Substance” means any substance
that is: (i) listed, classified or regulated pursuant to any Environmental Law; (ii) any petroleum product or by-product, asbestos-containing material, polychlorinated biphenyls, radioactive materials or radon; or (iii) any other
substance which is the subject of regulatory action by any Governmental Authority pursuant to any Environmental Law. 
 (y)
Taxes. The Company and its Subsidiaries have filed all necessary federal, state and foreign income and franchise tax returns when due (or obtained appropriate extensions for filing) and have paid or accrued all taxes shown as due
thereon, and the Company has no knowledge of a tax deficiency which has been or might be asserted or threatened against it or any Subsidiary which would have a Material Adverse Effect. 

(z) ERISA. Neither the Company nor any ERISA Affiliate maintains, contributes to or has any liability or contingent
liability with respect to any employee benefit plan subject to ERISA. 

  
 13 









 (aa) Foreign Assets Control Regulations and Anti-Money Laundering. 

(i) OFAC. Neither the issuance of the Shares and Warrants to the Investors, nor the use of the respective proceeds thereof,
shall cause the Investors to violate the U.S. Bank Secrecy Act, as amended, and any applicable regulations thereunder or any of the sanctions programs administered by the U.S. Department of the Treasury’s Office of Foreign Assets Control
(“OFAC”) of the United States Department of Treasury, any regulations promulgated thereunder by OFAC or under any affiliated or successor governmental or quasi-governmental office, bureau or agency and any enabling legislation or
executive order relating thereto. Without limiting the foregoing, neither the Company nor any Subsidiary (i) is a person whose property or interests in property are blocked or subject to blocking pursuant to Section 1 of Executive Order
13224 of September 23, 200l Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism (66 Fed. Reg. 49079 (2001)), (ii) engages in any dealings or transactions prohibited by
Section 2 of such executive order, or is otherwise associated with any such person in any manner violative of Section 2, or (iii) is a person on the list of Specially Designated Nationals and Blocked Persons or subject to the
limitations or prohibitions under any other OFAC regulation or executive order. 
 (ii) Patriot Act. The Company
and each of its Subsidiaries are in compliance, in all material respects, with the USA PATRIOT Act. No part of the proceeds of the sale of the Shares and the Warrants hereunder will be used, directly or indirectly, for any payments to any
governmental official or employee, political party, official of a political party, candidate for political office, or anyone else acting in an official capacity, in order to obtain, retain or direct business or obtain any improper advantage, in
violation of the United States Foreign Corrupt Practices Act of 1977, as amended. 
 (bb) Acknowledgment Regarding
Investors’ Trading Activity. Except as expressly set forth herein, it is understood and acknowledged by the Company that, except to the extent required by applicable law: (i) none of the Investors have been asked by the Company to
agree, nor has any Investor agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or “derivative” securities based on securities issued by the Company or to hold the Securities for any specified term;
(ii) that past or future open market or other transactions by any Investor, specifically including, without limitation, short sales or “derivative” transactions, before or after the closing of this or future private placement
transactions, may negatively impact the market price of the Company’s publicly-traded securities; (iii) that any Investor, and counter-parties in “derivative” transactions to which any such Investor is a party, directly or
indirectly, presently may have a “short” position in the Common Stock and (iv) that each Investor shall not be deemed to have any affiliation with or control over any arm’s length counter-party in any “derivative”
transaction. The Company further understands and acknowledges that, to the extent permitted by applicable law (y) one or more Investors may engage in hedging activities at various times during the period that the Securities are outstanding,
including, without limitation, during the periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing
stockholders’ equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction
Documents, except to the extent that any such activities violate the provisions of applicable law. 

  
 14 









 (cc) Regulation M Compliance. The Company has not, and to its knowledge no one
acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities,
(ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the
Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company’s placement agent in connection with the placement of the Securities. 
 (dd) Form S-3 Eligibility. The Company is eligible to register the resale of the Shares and the Warrant Shares for resale by the Investors on Form S-3 promulgated under the Securities Act;
provided, however, that no violation of this Section 3.1(dd) shall be deemed to have occurred in the event that the SEC imposes any restriction on the registration of the Shares and/or the Warrant Shares pursuant to Rule 415 as contemplated in
Section 4.1(a) below. 
 Section 3.2. Representations and Warranties of the Investor. Each Investor hereby
represents and warrants to the Company as follows: 
 (a) Authority. This Agreement has been duly executed by the
Investor, and when delivered by the Investor in accordance with terms hereof, will constitute the valid and legally binding obligation of the Investor, enforceable against him in accordance with its terms, except as such enforceability may be
limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general
application. 
 (b) Own Account. The Investor is acquiring the Securities as principal for its own account and not
with a view to or for distributing or reselling such Securities or any part thereof, without prejudice, however, to the Investor’s right at all times to sell or otherwise dispose of all or any part of such Securities in compliance with
applicable federal and state securities laws. The Investor does not have any agreement or understanding, directly or indirectly, with any Person to distribute any of the Securities. 

(c) Investor Status. The Investor is an “accredited investor” as defined in Rule 501(a) under the Securities Act
and a “qualified institutional buyer” as defined in Rule 144A under the Securities Act. The Investor is not a registered broker-dealer under Section 15 of the Exchange Act or associated or affiliated with such a broker-dealer. Any
Investor which is an entity has not been formed specifically for the purpose of investing in the Securities and has its principal place of business at the address listed for it on the signature pages hereto. 

(d) Access to Information. The Investor acknowledges that it has reviewed the SEC Reports and has been afforded
(i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in
the Securities; (ii) access to information about the Company and the Subsidiaries and their respective financial condition, results of operations, business, properties, management and prospects sufficient to enable him to evaluate his
investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the
investment. 

  
 15 









 (e) General Solicitation. The Investor is not purchasing the Securities as a
result of any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or
general advertisement. 
 (f) Disclosure. The Investor acknowledges and agrees that the Company neither makes nor
has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.1. 
 (g) Regulation M Compliance. The Investor has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in
the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities,
or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company. 
 ARTICLE 4 
 REGISTRATION RIGHTS 

Section 4.1. Shelf Registration. 
 (a) As promptly as possible, and in any event on or prior to the Filing Date, the Company shall prepare and file with the Commission a “shelf” Registration Statement covering the resale of all
Registrable Securities for an offering to be made on a continuous basis pursuant to Rule 415. If for any reason (including, without limitation, the Commission’s interpretation of Rule 415) the Commission does not permit all of the Registrable
Securities to be included in such Registration Statement, then the Company shall prepare and file with the Commission one or more separate Registration Statements with respect to any such Registrable Securities not included with the initial
Registration Statements, as soon as allowed under SEC Regulations and is commercially practicable. The Registration Statement shall be on a Form S-3; in the event Form S-3 is not available for the registration of the resale of Registrable Securities
hereunder, the Company shall (i) register the resale of the Registrable Securities on another appropriate form in accordance herewith and (ii) attempt to register the Registrable Securities on Form S-3 as soon as such form is available,
provided that the Company shall maintain the effectiveness of the Registration Statements then in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission. If at
any time the SEC takes the position that the offering of some or all of the Registrable Securities in a Registration Statement is not eligible to be made on a delayed or continuous basis under the provisions of Rule 415 under the 1933 Act or
requires any Investor to be named as an “underwriter”, the Company shall use its commercially reasonable best efforts to persuade the SEC that the offering contemplated by the Registration Statement is a valid secondary offering and not an
offering “by or on behalf of the issuer” as defined in Rule 415 and that none of the Investors is an “underwriter”. The Investors shall have the right to participate or 

  
 16 









 
have their counsel participate in any meetings or discussions with the SEC regarding the SEC’s position and to comment or have their counsel comment on any written submission made to the SEC
with respect thereto, and to have such comments relayed to the SEC with the consent of the Company, not to be unreasonably withheld. No such written submission shall be made to the SEC to which the Investors’ counsel reasonably objects. In the
event that, despite the Company’s commercially reasonable efforts and compliance with the terms of this Section 2(e), the SEC refuses to alter its position, the Company shall (i) remove from the Registration Statement such portion of
the Registrable Securities (the “Cut Back Shares”) and/or (ii) with the consent of the Investor’s counsel, not to be unreasonably withheld, agree to such restrictions and limitations on the registration and resale of the
Registrable Securities as the SEC may require to assure the Company’s compliance with the requirements of Rule 415; provided, however, that the Company shall not agree to name any Investor as an “underwriter” in such Registration
Statement without the prior written consent of such Investor (collectively, the “SEC Restrictions”). The Cut Back Shares shall be allocated among the Investors on a pro rata basis unless the SEC otherwise requires. No liquidated
damages shall accrue on or as to any Cut Back Shares until such time as the Company is able, using commercially reasonable efforts, to effect the filing of an additional Registration Statement with respect to the Cut Back Shares in accordance with
any SEC Restrictions (such date, the “Restriction Termination Date”). From and after the Restriction Termination Date, all of the provisions of this Article 4 (including the liquidated damages provisions) shall again be applicable
to the Cut Back Shares; provided, however, that for such purposes, references to the Filing Date shall be deemed to be the Restriction Termination Date. 
 (b) The Company shall use its best efforts to cause each Registration Statement filed hereunder to be declared effective by the Commission as promptly as possible after the filing thereof, but in any
event prior to the Required Effectiveness Date, and shall use its best efforts to keep the Registration Statement continuously effective under the Securities Act until the earlier of (i) the fifth anniversary of the Effective Date,
(ii) the date when all Registrable Securities covered by such Registration Statement have been sold publicly, or (iii) the date on which the Registrable Securities are eligible for sale without volume limitation within a three-month period
pursuant to Rule 144 or any successor thereto (the “Effectiveness Period”). The Company shall notify the Investor in writing promptly (and in any event within one Business Day) after receiving notification from the Commission that
the Registration Statement has been declared effective. 
 (c) As promptly as possible, and in any event no later than the
Post-Effective Amendment Filing Deadline, the Company shall prepare and file with the Commission a Post-Effective Amendment. The Company shall use its best efforts to cause the Post-Effective Amendment to be declared effective by the Commission as
promptly as possible after the filing thereof. The Company shall notify the investor in writing promptly (and in any event within one Business Day) after receiving notification from the Commission that the Post-Effective Amendment has been declared
effective. 
 (d) If: (i) any Registration Statement is not filed on or prior to the Filing Date (or the Restriction
Termination Date, as applicable) or a Post-Effective Amendment is not filed on or prior to the Post-Effective Amendment Filing Deadline, or (ii) the Company fails to file with the Commission a request for acceleration of effectiveness in
accordance with Rule 461 

  
 17 









 
promulgated under the Securities Act, within seven (7) Business Days after the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that a
Registration Statement will not be “reviewed,” or will not be subject to further review, or (iii) the Company fails to respond to any comments made by the Commission within fifteen (15) Business Days after the receipt of such
comments, or (iv) a Registration Statement filed hereunder is not declared effective by the Commission by the Required Effectiveness Date, or a Post-Effective Amendment is not declared effective on or prior to the fifteenth Business Day
following the Post-Effective Amendment Filing Deadline, or (v) after a Registration Statement is filed with and declared effective by the Commission, such Registration Statement ceases to be effective as to all Registrable Securities to which
it is required to relate at any time prior to the expiration of the Effectiveness Period for a period of more than thirty (30) days without being succeeded by an amendment to such Registration Statement or by a subsequent Registration Statement
filed with and declared effective by the Commission, but excluding the Tolling Period (as defined below), or (vi) an amendment to a Registration Statement is not filed by the Company with the Commission within fifteen (15) Business Days
after the Commission’s having notified the Company that such amendment is required in order for such Registration Statement to be declared effective, but excluding the Tolling Period, or (vii) after a Registration Statement is filed with
and declared effective by the Commission, the Company advises the Investors that the Prospectus no longer may be used because it does not comply with applicable laws, rules and regulations, but the Prospectus can be supplemented to so comply without
amending the Registration Statements, and the Company fails to provide a supplement so complying within fifteen (15) Business Days thereafter, but excluding the Tolling Period (any such failure or breach being referred to as an
“Event” and the date on which such Event occurs being referred to as “Event Date”), then: (x) on each such Event Date the Company shall pay to the Investor an amount in cash, as liquidated damages and not as a
penalty, equal to one-tenth of one percent (0.1%) of the aggregate Purchase Price paid by the Investor pursuant to this Agreement for the Registrable Securities covered by such Registration Statement (the “Penalty Base”); and
(y) on the same day of each successive month following such Event Date (so long as the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to the Investor an amount in cash, as
liquidated damages and not as a penalty, equal to one-tenth of one percent (0.1%) of the Penalty Base. Notwithstanding the foregoing, in no event shall the Company be obligated to pay any liquidated damages pursuant to this Section 4.1(d) of
more than one percent (1.0%) of the aggregate Purchase Price. Such payments shall be the Investor’s sole and exclusive remedy for such Events. If the Company fails to pay any liquidated damages pursuant to this Section in full within seven
(7) Business Days after the date payable, the Company will pay interest thereon at a rate of eight percent (8.0%) per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Investor, accruing daily from
the date such liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. For the avoidance of doubt, any Event shall be deemed to have been cured and no further liquidated damages shall accrue with respect
thereto upon the end of the Effectiveness Period; provided, however, that the Company shall not be relieved of any liability it may have hereunder (including the payment of liquidated damages) accruing prior to the end of the Effectiveness Period.

 (e) Notwithstanding the foregoing, the periods set forth in Section 4.1(d)(v), (vi) and (vii) may be tolled
for not more than twenty (20) consecutive days or for a total of not more than forty-five (45) days in any twelve (12) month period, if the Company determines in 

  
 18 









 
good faith that such tolling period is necessary to delay the disclosure of material non-public information concerning the Company, the disclosure of which at the time is not, in the good faith
opinion of the Company, in the best interests of the Company (the “Tolling Period”); provided, that the Company shall promptly (a) notify each Investor in writing of the commencement of and the reasons for the Tolling Period,
but shall not (without the prior written consent of an Investor) disclose to such Investor any material non-public information giving rise to such Tolling Period, (b) advise the Investors in writing to cease all sales under the Registration
Statement until the end of such Tolling Period, and (c) use commercially reasonable efforts to terminate such Tolling Period as promptly as practicable. 
 (f) The Company shall not, prior to the Effective Date of the Registration Statement, prepare and file with the Commission a registration statement relating to an offering for its own account or the
account of others under the Securities Act of any of its equity securities. 
 (g) If the Company issues to the Investor any
Common Stock pursuant to the Transaction Documents that is not included in the initial Registration Statement, then the Company shall file an additional Registration Statement covering such number of shares of Common Stock on or prior to the Filing
Date and shall use it best efforts, but in no event later than the Required Effectiveness Date, to cause such additional Registration Statement to be declared effective by the Commission. 

(h) The Registration Statement shall not include any securities other than the Registrable Securities without the prior written consent
of the Investors then owning a majority of the Registrable Securities then owned by all of the Investors. 
 Section 4.2.
Registration Process. In connection with the registration of the Registrable Securities pursuant to Section 4.1, the Company shall: 
 (a) Prepare and file with the Commission the Registration Statement and such amendments (including post effective amendments) to the Registration Statement and supplements to the prospectus included
therein (a “Prospectus”) as the Company may deem necessary or appropriate and take all lawful action such that the Registration Statement and any amendment thereto does not, when it becomes effective, contain an untrue statement of
a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, not misleading and that the Prospectus forming part of the Registration Statement, and any amendment or supplement thereto,
does not at any time during the Registration Period include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which
they were made, not misleading.; 
 (b) Comply with the provisions of the Securities Act with respect to the Registrable
Securities covered by the Registration Statement until the end of the Effectiveness Period; 

  
 19 









 (c) Prior to the filing with the Commission of the Registration Statement (including any
amendments thereto) and the distribution or delivery of any Prospectus (including any supplements thereto), provide draft copies thereof to the Investor and reflect in such documents all such comments as the Investor (and its counsel) reasonably may
propose and furnish to the Investor and its legal counsel identified to the Company (i) promptly after the same is prepared and publicly distributed, filed with the Commission, or received by the Company, one copy of the Registration Statement,
each Prospectus, and each amendment or supplement thereto, and (ii) such number of copies of the Prospectus and all amendments and supplements thereto and such other documents, as the Investor may reasonably request in order to facilitate the
disposition of the Registrable Securities; 
 (d) (i) register or qualify the Registrable Securities covered by the Registration
Statement under such securities or “blue sky” laws of such jurisdictions as the Investors reasonably request, (ii) prepare and file in such jurisdictions such amendments (including post effective amendments) and supplements to such
registrations and qualifications as may be necessary to maintain the effectiveness thereof at all times during the Registration Period, (iii) take all such other lawful actions as may be necessary to maintain such registrations and
qualifications in effect at all times during the Registration Period, and (iv) take all such other lawful actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided, however, that
the Company shall not be required in connection therewith or as a condition thereto to (A) qualify to do business in any jurisdiction where it would not otherwise be required to qualify, (B) subject itself to general taxation in any such
jurisdiction or (C) file a general consent to service of process in any such jurisdiction; 
 (e) As promptly as
practicable after becoming aware of such event, notify the Investor of the occurrence of any event, as a result of which the Prospectus included in the Registration Statement, as then in effect, includes an untrue statement of a material fact or
omits to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and promptly prepare an amendment to the Registration Statement and
supplement to the Prospectus to correct such untrue statement or omission, and deliver a number of copies of such supplement and amendment to each Investor as such Investor may reasonably request; 

(f) As promptly as practicable after becoming aware of such event, notify the Investor (or, in the event of an underwritten offering, the
managing underwriters) of the issuance by the Commission of any stop order or other suspension of the effectiveness of the Registration Statement and take all lawful action to effect the withdrawal, rescission or removal of such stop order or other
suspension; 
 (g) Take all such other lawful actions reasonably necessary to expedite and facilitate the disposition by the
Investor of his Registrable Securities in accordance with the intended methods therefor provided in the Prospectus which are customary under the circumstances; 
 (h) Make generally available to its security holders as soon as practicable, but in any event not later than 18 months after the Effective Date of the Registration Statement, an earnings statement of the
Company and its subsidiaries complying with Section 11(a) of the Securities Act and the rules and regulations of the Commission thereunder; 

  
 20 









 (i) In the event of an underwritten offering, promptly include or incorporate in a
Prospectus supplement or post effective amendment to the Registration Statement such information as the underwriters reasonably agree should be included therein and to which the Company does not reasonably object and make all required filings of
such Prospectus supplement or post effective amendment as soon as practicable after it is notified of the matters to be included or incorporated in such Prospectus supplement or post effective amendment; 

(j) Make reasonably available for inspection by the Investor, any underwriter participating in any disposition pursuant to the
Registration Statement, and any attorney, accountant or other agent retained by such Investors or any such underwriter all relevant financial and other records, pertinent corporate documents and properties of the Company and its subsidiaries, and
cause the Company’s officers, directors and employees to supply all information reasonably requested by the Investor or any such underwriter, attorney, accountant or agent in connection with the Registration Statement, in each case, as is
customary for similar due diligence examinations; provided, however, that all records, information and documents that are designated in writing by the Company, in good faith, as confidential, proprietary or containing any nonpublic information shall
be kept confidential by such Investors and any such underwriter, attorney, accountant or agent (pursuant to an appropriate confidentiality agreement in the case of any such holder or agent), unless such disclosure is made pursuant to judicial
process in a court proceeding (after first giving the Company an opportunity promptly to seek a protective order or otherwise limit the scope of the information sought to be disclosed) or is required by law, or such records, information or documents
become available to the public generally or through a third party not in violation of an accompanying obligation of confidentiality; and provided, further, that, if the foregoing inspection and information gathering would otherwise disrupt the
Company’s conduct of its business, such inspection and information gathering shall, to the maximum extent possible, be coordinated on behalf of the Investors and the other parties entitled thereto by one firm of counsel designated by and on
behalf of the majority in interest of Investors and other parties; 
 (k) In connection with any offering, make such
representations and warranties to the Investor and to the underwriters if an underwritten offering, in form, substance and scope as are customarily made by a company to underwriters in secondary underwritten offerings; 

(l) In connection with any underwritten offering, deliver such documents and certificates as may be reasonably required by the
underwriters; 
 (m) Cooperate with the Investor to facilitate the timely preparation and delivery of certificates representing
Registrable Securities to be sold pursuant to the Registration Statement, which certificates shall, if required under the terms of this Agreement, be free of all restrictive legends, and to enable such Registrable Securities to be in such
denominations and registered in such names as any Investor may request and maintain a transfer agent for the Common Stock; 

(n) Use its commercially reasonable efforts to cause all Registrable Securities covered by the Registration Statement to be listed or
qualified for trading on the principal Trading Market, if any, on which the Common Stock is traded or listed on the Effective Date of the Registration Statement; and 

  
 21 









 (o) Unless and to the extent that such Plan of Distribution requires modification due to
inaccuracy, due to changes in the plan of distribution of Investor, or due to a change in SEC regulations, to use the Plan of Distribution attached hereto as Exhibit D in each Prospectus and Registration Statement. 

Section 4.3. Obligations and Acknowledgements of the Investors. In connection with the registration of the Registrable
Securities, each Investor shall have the following obligations and hereby make the following acknowledgements: 
 (a) It shall
be a condition precedent to the obligations of the Company to include the Registrable Securities in the Registration Statement that the Investor (i) shall furnish to the Company such information regarding itself, the Registrable Securities held
by it and the intended method of disposition of the Registrable Securities held by it as shall be reasonably required to effect the registration of such Registrable Securities and (ii) shall execute such documents in connection with such
registration as the Company may reasonably request. At least five (5) Business Days prior to the first anticipated filing date of a Registration Statement, the Company shall notify the Investor of the information the Company requires from the
Investor (the “Requested Information”) if the Investor elects to have any of its Registrable Securities included in the Registration Statement. If at least two (2) Business Days prior to the anticipated filing date the Company
has not received the Requested Information from the Investor, then the Company may file the Registration Statement without including any Registrable Securities of the Investor and the Company shall have no further obligations under this Article 4 to
the Investor after such Registration Statement has been declared effective. If the Investor notifies the Company and provides the Company the information required hereby prior to the time the Registration Statement is declared effective, the Company
will file an amendment to the Registration Statement that includes the Registrable Securities of the Investor; provided, however, that the Company shall not be required to file such amendment to the Registration Statement at any time less than five
(5) Business Days prior to the Effectiveness Date; 
 (b) The Investor agrees to cooperate with the Company in connection
with the preparation and filing of a Registration Statement hereunder, unless the Investor has notified the Company in writing of its election to exclude all of its Registrable Securities from such Registration Statement; and 

(c) The Investor agrees that, upon receipt of any notice from the Company of the occurrence of any event of the kind described in
Section 4.2(e) or 4.2(f), the Investor shall immediately discontinue its disposition of Registrable Securities pursuant to the Registration Statement covering such Registrable Securities until the Investor’s receipt of the copies of the
supplemented or amended Prospectus contemplated by Section 4.2(e) and, if so directed by the Company, the Investor shall deliver to the Company (at the expense of the Company) or destroy (and deliver to the Company a certificate of destruction)
all copies in the Investor’s possession (other than one copy of any documents not filed with the SEC for evidentiary purposes), of the Prospectus covering such Registrable Securities current at the time of receipt of such notice. 

Section 4.4. Expenses of Registration. All expenses (other than underwriting discounts and commissions and the fees an
expenses of the Investor’s counsel) incurred in connection with registrations, filings or qualifications pursuant to this Article 4, including, without limitation, all registration, listing, and qualifications fees, printing and engraving fees,
accounting fees, and the fees and disbursements of counsel for the Company, shall be borne by the Company. 

  
 22 









 Section 4.5. Accountant’s Letter. If the Investor proposes to engage in
an underwritten offering, the Company shall deliver to the Investor, at the Company’s expense, a letter dated as of the effective date of each Registration Statement or Post-Effective Amendment thereto, from the independent public accountants
retained by the Company, addressed to the underwriters and to the Investors, in form and substance as is customarily given in an underwritten public offering, provided that such seller has made such representations and furnished such undertakings as
the independent public accountants may reasonably require. 
 Section 4.6. Indemnification and Contribution

 (a) Indemnification by the Company. The Company shall indemnify and hold harmless the Investor and each
underwriter, if any, which facilitates the disposition of Registrable Securities, and each of their respective officers and directors and each Person who controls such underwriter within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act (each such Person being sometimes hereinafter referred to as an “Indemnified Person”) from and against any losses, claims, damages or liabilities, joint or several, to which such Indemnified
Person may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact
contained in any Registration Statement or an omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, not misleading, or arise out of or are based upon an untrue
statement or alleged untrue statement of a material fact contained in any Prospectus or an omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; and the Company hereby agrees to reimburse such Indemnified Person for all reasonable legal and other expenses incurred by them in connection with investigating or defending any such action
or claim as and when such expenses are incurred; provided, however, that the Company shall not be liable to any such Indemnified Person in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon
(i) an untrue statement or alleged untrue statement made in, or an omission or alleged omission from, such Registration Statement or Prospectus in reliance upon and in conformity with written information furnished to the Company by such
Indemnified Person expressly for use therein or (ii) in the case of the occurrence of an event of the type specified in Section 4.2(e), the use by the Indemnified Person of an outdated or defective Prospectus after the Company has provided
to such Indemnified Person an updated Prospectus correcting the untrue statement or alleged untrue statement or omission or alleged omission giving rise to such loss, claim, damage or liability. 

(b) Indemnification by Investors. Each Investor agrees, as a consequence of the inclusion of any of its Registrable
Securities in a Registration Statement, to (i) indemnify and hold harmless the Company, its directors (including any person who, with his or her consent, is named in the Registration Statement as a director nominee of the Company), its officers
who sign any Registration Statement and each Person, if any, who controls the Company within the 

  
 23 









 
meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act, against any losses, claims, damages or liabilities to which the Company or such other persons may
become subject, under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (A) an untrue statement or alleged untrue statement of a material fact
contained in such Registration Statement or Prospectus or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in light of the
circumstances under which they were made, in the case of the Prospectus), not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in reliance
upon and in conformity with written information furnished to the Company by the Investor expressly for use therein or (B) the use by an Investor of an outdated Prospectus from and after receipt by the Investor of a notice pursuant to
Section 4.2(e), and (ii) reimburse the Company for any legal or other expenses incurred by the Company in connection with investigating or defending any such action or claim as such expenses are incurred; provided, however, that the
Investor shall not be liable under this Section 4.6(b) for any amount in excess of the net proceeds paid to the Investor in respect of Registrable Securities sold by it. 
 (c) Notice of Claims, etc. Promptly after receipt by a Person seeking indemnification pursuant to this Section 4.6 (an “Indemnified Party”) of written notice of any
investigation, claim, proceeding or other action in respect of which indemnification is being sought (each, a “Claim”), the Indemnified Party promptly shall notify the Person against whom indemnification pursuant to this
Section 4.6 is being sought (the “Indemnifying Party”) of the commencement thereof; but the omission to so notify the Indemnifying Party shall not relieve it from any liability that it otherwise may have to the Indemnified
Party, except to the extent that the Indemnifying Party is materially prejudiced and forfeits substantive rights and defenses by reason of such failure. In connection with any Claim as to which both the Indemnifying Party and the Indemnified Party
are parties, the Indemnifying Party shall be entitled to assume the defense thereof. Notwithstanding the assumption of the defense of any Claim by the Indemnifying Party, the Indemnified Party shall have the right to employ separate legal counsel
and to participate in the defense of such Claim, and the Indemnifying Party shall bear the reasonable fees, out of pocket costs and expenses of such separate legal counsel to the Indemnified Party if (and only if): (i) the Indemnifying Party
shall have agreed to pay such fees, costs and expenses, (ii) the Indemnified Party shall reasonably have concluded that representation of the Indemnified Party by the Indemnifying Party by the same legal counsel would not be appropriate due to
actual or, as reasonably determined by legal counsel to the Indemnified Party, potentially differing interests between such parties in the conduct of the defense of such Claim, or if there may be legal defenses available to the Indemnified Party
that are in addition to or disparate from those available to the Indemnifying Party (other than that the Indemnified Party is entitled to be indemnified by the Indemnifying Party), or (iii) the Indemnifying Party shall have failed to employ
legal counsel reasonably satisfactory to the Indemnified Party within a reasonable period of time after notice of the commencement of such Claim. If the Indemnified Party employs separate legal counsel in circumstances other than as described in the
preceding sentence, the fees, costs and expenses of such legal counsel shall be borne exclusively by the Indemnified Party. Except as provided above, the Indemnifying Party shall not, in connection with any Claim in the same jurisdiction, be liable
for the fees and expenses of more than one firm of counsel for the Indemnified Party (together with appropriate 

  
 24 









 
local counsel). The Indemnified Party shall not, without the prior written consent of the Indemnifying Party (which consent shall not unreasonably be withheld), settle or compromise any Claim or
consent to the entry of any judgment that does not include an unconditional release of the Indemnifying Party from all liabilities with respect to such Claim or judgment or contain any admission of wrongdoing. 

(d) Contribution. If the indemnification provided for in this Section 4.6 is unavailable to or insufficient to hold
harmless an Indemnified Party in respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred to therein, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party as a
result of such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and the Indemnified Party in connection with the statements or
omissions or alleged statements or omissions which resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and
Indemnified Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by such
Indemnifying Party or by such Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The parties hereto agree that it would not be just and
equitable if contribution pursuant to this Section 4.6(d) were determined by pro rata allocation (even if the Investors or any underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take
account of the equitable considerations referred to in this Section 4.6(d). The amount paid or payable by an Indemnified Party as a result of the losses, claims, damages or liabilities (or actions in respect thereof) referred to above shall be
deemed to include any legal or other fees or expenses reasonably incurred by such Indemnified Party in connection with investigating or defending any such action or claim. No person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. 
 (e) Limitation on Investors’ Obligations. Notwithstanding any other provision of this Section 4.6, in no event shall any Investor have any liability under this Section 4.6 for
any amounts in excess of the dollar amount of the proceeds actually received by the Investor from the sale of Registrable Securities (after deducting any fees, discounts and commissions applicable thereto) pursuant to any Registration Statement
under which such Registrable Securities are registered under the Securities Act. 
 (f) Other Liabilities. The
obligations of the parties under this Section 4.6 shall be in addition to any liability which such party may otherwise have to any Indemnified Person and the obligations of any Indemnified Person under this Section 4.6 shall be in addition
to any liability which such Indemnified Person may otherwise have to any other party. The remedies provided in this Section 4.6 are not exclusive and shall not limit any rights or remedies which may otherwise be available to an indemnified
party at law or in equity. 

  
 25 









 Section 4.7. Rule 144. With a view to making available to the Investor the
benefits of Rule 144 or any successor thereto, until the shares are eligible for sale without volume limitations, the Company agrees to use its best efforts to: 
 (i) comply with the provisions of paragraph (c)(1) of Rule 144 or any successor thereto; and 
 (ii) file with the Commission in a timely manner all reports and other documents required to be filed by the Company pursuant to Section 13 or 15(d) under the Exchange Act; and, if at any time it is
not required to file such reports but in the past had been required to or did file such reports, it will, upon the request of any Investor, make available other information as required by, and so long as necessary to permit sales of, its Registrable
Securities pursuant to Rule 144 or any successor thereto. 
 Section 4.8. Common Stock Issued Upon Stock Split,
etc. The provisions of this Article 4 shall apply to any shares of Common Stock or any other securities issued as a dividend or distribution in respect of the Shares or the Warrant Shares. 

Section 4.9. Tolling of Deadline. Notwithstanding any provision of this Article 4 or of this Agreement to the
contrary, if required by Commission regulation or rule, the Company shall have the right to delay the filing with the Commission of an S-3 registration statement for so long as is necessary to allow the Company to file the S-3 registration statement
with the Commission at least thirty (30) days after the filing with the Commission of its annual report on Form 10-K for the fiscal year ended December 31, 2011, without any repercussion or penalty. 

ARTICLE 5 

OTHER AGREEMENTS OF THE PARTIES 
 Section 5.1. Certificates; Legends. 
 (a) The Securities may only be
transferred in compliance with state and federal securities laws. In connection with any transfer of the Securities other than (i) pursuant to an effective registration statement, (ii) to the Company, or (iii) to an Affiliate of the
Investor, the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to
the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act or applicable state securities laws. In the event of a private transfer of the Securities the Transferee shall be
required to execute a counterpart to this Agreement, agreeing to be bound by (and shall have the benefits of) the terms hereof other than those set forth in Article 2 hereof, and such Transferee shall be deemed to be an “Investor” for
purposes of this Agreement. 
 (b) The certificates representing the Shares and the Warrants to be delivered at the Closing, and
the certificates evidencing the Warrant Shares to be delivered upon exercise of the Warrants, will contain appropriate legends referring to restrictions on transfer relating to the registration requirements of the Securities Act and applicable state
securities laws. 

  
 26 









 (c) In connection with any sale or disposition of the Securities by an Investor pursuant to
Rule 144 or pursuant to any other exemption under the 1933 Act such that the purchaser acquires freely tradable shares and upon compliance by the Investor with the requirements of this Agreement, the Company shall or, in the case of Common Stock,
shall cause the transfer agent for the Common Stock (the “Transfer Agent”), to issue replacement certificates representing the Securities sold or disposed of without restrictive legends. Upon the earlier of (i) registration for
resale pursuant to the Registration Rights Agreement or (ii) the Shares becoming freely tradable without restriction pursuant to Rule 144 the Company shall (A) deliver to the Transfer Agent irrevocable instructions that the Transfer Agent
shall reissue a certificate representing shares of Common Stock without legends upon receipt by such Transfer Agent of the legended certificates for such shares, and, in the case of a proposed sale pursuant to Rule 144, a customary representation by
the Investor that the conditions required to freely sell the shares of Common Stock represented thereby without restriction pursuant to Rule 144 have been satisfied, and (B) cause its counsel to deliver to the Transfer Agent one or more blanket
opinions to the effect that the removal of such legends in such circumstances may be effected under the 1933 Act. From and after the earlier of such dates, upon an Investor’s written request, the Company shall promptly cause certificates
evidencing the Investor’s Securities to be replaced with certificates which do not bear such restrictive legends, and Warrant Shares subsequently issued upon due exercise of the Warrants shall not bear such restrictive legends provided the
provisions of either clause (i) or clause (ii) above, as applicable, are satisfied with respect to such Warrant Shares. When the Company is required to cause an unlegended certificate to replace a previously issued legended certificate,
if: (1) the unlegended certificate is not delivered to an Investor within three (3) Business Days of submission by that Investor of a legended certificate and supporting documentation to the Transfer Agent as provided above and
(2) prior to the time such unlegended certificate is received by the Investor, the Investor, or any third party on behalf of such Investor or for the Investor’s account, purchases (in an open market transaction or otherwise) shares of
Common Stock to deliver in satisfaction of a sale by the Investor of shares represented by such certificate (a “Buy-In”), then the Company shall pay in cash to the Investor (for costs incurred either directly by such Purchaser or on
behalf of a third party) the amount by which the total purchase price paid for Common Stock as a result of the Buy-In (including brokerage commissions, if any) exceeds the proceeds received by such Investor as a result of the sale to which such
Buy-In relates. The Investor shall provide the Company written notice indicating the amounts payable to the Investor in respect of the Buy-In. 
 (d) Notwithstanding the provisions of this Section 5.1 relating to certificates, an Investor may choose to evidence the Investor’s ownership of Shares and Warrant Shares in book entry form on
the records of the Transfer Agent or through the Direct Registration System of The Depository Trust Company. To the extent appropriate and feasible, the provisions of this Section 5.1 shall continue to apply to Shares and to Warrant Shares
whose ownership is evidenced in such form. 
 Section 5.2. Integration. The Company has not and shall not, and
shall use its best efforts to ensure that no Affiliate of the Company shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be
integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities to the Investor, or that would be integrated with the offer or sale of the Securities for
purposes of the rules and regulations of any Trading Market in a manner that would require stockholder approval of the sale of the securities to the Investor. 

  
 27 









 Section 5.3. Securities Laws Disclosure; Publicity. By 5:00 p.m. (New York
time) on the Closing Date, the Company shall issue a press release disclosing the material terms of the transactions contemplated hereby and the Closing. On the third Trading Day following the Closing Date the Company will file a Current Report on
Form 8-K disclosing the material terms of the Transaction. In addition, the Company will make such other filings and notices in the manner and time required by the Commission. 
 Section 5.4. Use of Proceeds. The Company shall use the net proceeds from the sale of the Securities hereunder (i) to redeem existing secured debt, (ii) for working capital
purposes, (iii) to purchase fixed assets used in the development or production of the Company’s products, or (iv) for investment in new technologies related to the Company’s business (including without limitation through the
acquisition of other companies). 
 Section 5.5. Right of First Refusal 

(a) Proposed Financings. In the event that, during the period commencing on the Closing Date and continuing to the second
anniversary of the Closing Date, the Company seeks to raise additional funds through a private placement of its equity or equity related securities to one or more accredited investors (a “Proposed Financing”), other than Exempt
Issuances, each Investor investing a minimum of $100,000 at the Closing (a “Qualified Investor”) shall have the right to participate in the Proposed Financing on a pro rata basis, based on the percentage that (a) the number of
shares of Common Stock then held by such Qualified Investor plus the number of shares of Common Stock issuable upon conversion of the Warrants held by such Qualified Investor bears to (b) the total number of shares of Common Stock
outstanding plus the number of shares of Common Stock issuable upon conversion of the Warrants, the Prior Warrants, the Prior Convertible Securities and the Company Stock Options. 

(b) Pre-Notice of Proposed Financings. At least five (5) Business Days prior to the closing of any Proposed Financing,
the Company shall deliver to each Qualified Investor a written notice of its intention to effect a Proposed Financing (“Pre-Notice”), which Pre-Notice shall ask such Investor if it wants to review the details of such financing (such
additional notice, a “Proposed Financing Notice”). Each such Qualified Investor hereby consents to the delivery of any such Pre-Notice by the Company. Upon the request of a Qualified Investor, and only upon a request by such
Qualified Investor, for a Proposed Financing Notice, the Company shall promptly, but no later than one Business Day after such request, deliver a Proposed Financing Notice to such Qualified Investor. The Proposed Financing Notice shall describe in
reasonable detail the proposed terms of such Proposed Financing, the amount of proceeds intended to be raised thereunder, the lead investor with whom such Proposed Financing is proposed to be effected, and attached to which shall be a term sheet or
similar document relating thereto. Each Qualified Investor wishing to participate in the Proposed Financing shall notify the Company in writing by 6:30 p.m. (New York City time) on the second (2nd) Business Day after its receipt of the Proposed
Financing Notice of its willingness to participate in the Proposed Financing on the terms described in the Proposed Financing Notice, subject to completion of mutually acceptable documentation and diligence investigation (such Qualified


  
 28 









 
Investor, a “Participating Investor”). Any Qualified Investor who fails to provide a timely notice of its willingness to so participate shall be deemed to have irrevocably waived its
right to participate in the Proposed Financing. The Company shall promptly provide to Participating Investors such diligence materials as they may reasonably request, subject to execution of a non-disclosure agreement, in customary form, mutually
acceptable to the parties. 
 (c) Investment Terms. The terms on which a Participating Investor shall purchase
securities pursuant to the Proposed Financing shall be the same as such securities are purchased by other investors in such Proposed Financing. In the event that the terms of the Proposed Financing are changed in a manner which is material to the
Participating Investors, the Company shall provide the Participating Investors with the same notice of the revised terms that are provided to the other investors in such Proposed Financing, and, shall provide the Participating Investors the same
amount of time as is provided to the other investors in such Proposed Financing to allow the Participating Investors to review the revised terms of the Proposed Financing and the Company’s financial condition and prospects in light of the
changed terms. In no event shall any change in the terms of a Proposed Financing give any Qualified Investor which is not a Participating Investor the right to participate in such Proposed Financing. 

(d) Financings. The Company may sell any securities not purchased by the Participating Investors in the Proposed Financing
at a price and on terms which are no more favorable to the investors in such Proposed Financing than the terms disclosed to the Participating Investors pursuant to this Section 5.5. 

Section 5.6. Equal Treatment of Investors. No consideration shall be offered or paid to any Person to amend or consent to a
waiver or modification of any provision of any of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right
granted to each Investor by the Company and negotiated separately by each Investor, and is intended for the Company to treat the Investors as a class and shall not in any way be construed as the Investors acting in concert or as a group with respect
to the purchase, disposition or voting of Securities or otherwise. 
 Section 5.7. Prospectus Delivery
Requirements. Each Investor, severally and not jointly with the other Investors, agrees that such Investor will not effect any sale, transfer or other disposition of any Securities except pursuant to either the registration requirements of
the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth
therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth in Section 4.1 is predicated upon the Company’s reliance upon this understanding. 

Section 5.8. Reservation of Common Stock. From and after the Closing Date, the Company shall reserve and keep available at
all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue the Warrant Shares pursuant to any exercise of the Warrants. 

  
 29 









 Section 5.9. Subsequent Equity Sales. For a period of three (3) months
from the final Closing Date in the transaction covered by this Agreement, the Company shall not issue any shares of Common Stock or Common Stock Equivalents, other than pursuant to an Exempt Issuance. 

Section 5.10. Disclosure of Information. Except for the delivery of one or more Pre-Notices as contemplated by
Section 5.5, except upon the prior written consent of an Investor, the Company shall not disclose any material non-public information to such Investor or its counsel. Any such disclosure shall be made pursuant to an in accordance with a
customary non-disclosure agreement between the Company and such Investor. 
 Section 5.11. Furnishing of
Information. If the Common Stock is not registered under Section 12(b) or 12(g) of the Exchange Act on the date hereof, the Company agrees to cause the Common Stock to be registered under Section 12(g) of the Exchange Act on or
before the 60th calendar day following the date hereof. Until the earliest of the time that (i) no Investor owns Securities or (ii) the Warrants have expired, the Company covenants to maintain the registration of the Common Stock under
Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange
Act. As long as any Investor owns Securities, if the Company is not required to file reports pursuant to the Exchange Act, it will prepare and furnish to the Investors and make publicly available in accordance with Rule 144(c) such information as is
required for the Investors to sell the Securities under Rule 144. The Company further covenants that it will take such further action as any holder of Securities may reasonably request, to the extent required from time to time to enable such Person
to sell such Securities without registration under the Securities Act within the requirements of the exemption provided by Rule 144. 
 ARTICLE 6 
 CONDITIONS PRECEDENT TO CLOSING 

Section 6.1. Conditions Precedent to the Obligations of the Investor to Purchase Securities. The obligation of the Investor
to acquire Securities at any Closing is subject to the satisfaction or waiver by the Investor, at or before the Closing, of each of the following conditions: 
 (a) Representations and Warranties. The Company shall have delivered a certificate of the Company’s Chief Executive Officer certifying that the representations and warranties of the
Company contained herein are true and correct in all material respects as of the date when made and as of the Closing Date as though made on and as of such Closing Date; 
 (b) Performance. The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by the Transaction Documents to be
performed, satisfied or complied with by it at or prior to the Closing; 
 (c) No Injunction. No statute, rule,
regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents; 

  
 30 









 (d) No Adverse Changes. Since the date of execution of this Agreement, no
event or series of events shall have occurred that reasonably could have or result in a Material Adverse Effect; 
 (e)
Company Deliverables. The Company shall have delivered the Company Deliverables in accordance with Section 2.4. 
 Section 6.2. Conditions Precedent to the Obligations of the Company to Sell Securities. The obligation of the Company to sell Securities at any Closing is subject to the satisfaction or
waiver by the Company, at or before the Closing, of each of the following conditions: 
 (a) Representations and
Warranties. The representations and warranties of each Investor contained herein shall be true and correct in all material respects as of the date when made and as of the Closing Date as though made on and as of such date; 

(b) Performance. Each Investor shall have performed, satisfied and complied in all material respects with all covenants,
agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by such Investor at or prior to the Closing; 
 (c) No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental
authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents; and 
 (d) Purchase Price. Each Investor shall have paid its pro rata portion of the Purchase Price in accordance with Section 2.2. 

ARTICLE 7 

MISCELLANEOUS 
 Section 7.1. Fees and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party
incident to the negotiation, preparation, execution, delivery and performance of the Transaction Documents. The Company shall pay all stamp and other taxes and duties levied in connection with the sale of the Shares. 

Section 7.2. Entire Agreement. The Transaction Documents, together with the Exhibits thereto, contain the entire
understanding of the parties with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions and representations, oral or written, with respect to such matters, which the parties acknowledge have been merged
into such documents and exhibits. 

  
 31 









 Section 7.3. Notices. Any and all notices or other communications or
deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via facsimile (provided the
sender receives a machine-generated confirmation of successful transmission) at the facsimile number specified in this Section prior to 6:30 p.m. on a Business Day, (b) the next Business Day after the date of transmission, if such notice or
communication is delivered via facsimile at the facsimile number specified in this Section on a day that is not a Business Day or later than 6:30 p.m. on any Business Day, (c) the Business Day following the date of transmission, if sent by a
nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as follows: 

 

			
	 If to the Company:
	  	 Energy Focus, Inc.
 32000
Aurora Road
 Solon, Ohio 44139

Telephone: (440) 715-1300
 Facsimile: (440)
519-1038
 Attention: Chief Financial Officer

		
	 With a copy to:
	  	 Cowden & Humphrey Co. LPA

4600 Euclid Avenue, Suite 400
 Cleveland, Ohio
44103
 Telephone: (216) 241-2880

Facsimile: (216) 241-2881
 Attention: Gerald W.
Cowden


 or if to an Investor at such address as is listed on Exhibit A attached hereto or such other address as may be
designated by an Investor or the Company in writing hereafter, in the same manner, by such Person. 
 Section 7.4.
Amendments; Waivers; No Additional Consideration. No provision of this Agreement may be waived or amended except in a written instrument signed by the Company and the Investors acquiring at least 66 and 2/3ds of the Securities sold at
the Closing Date. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision,
condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right. 
 Section 7.5. Termination. This Agreement may be terminated prior to the Closing by written agreement of the Investors and the Company. Upon a termination in accordance with this
Section 7.5, the Company and the Investor shall have no further obligation or liability (including as arising from such termination) to the other, provided that any liabilities arising prior to such termination shall not be affected by the
termination. 

  
 32 









 Section 7.6. Construction. The headings herein are for convenience only, do
not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules
of strict construction will be applied against any party. This Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any
provisions of this Agreement or any of the Transaction Documents. 
 Section 7.7. Successors and Assigns. This
Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. No party may assign this Agreement or any rights or obligations hereunder without the prior written consent of the other parties.

 Section 7.8. No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and
their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.6 (with respect to rights to indemnification and
contribution). 
 Section 7.9. Governing Law. All questions concerning the construction, validity, enforcement and
interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflicts of law thereof. Each party agrees that all Proceedings
concerning the interpretations, enforcement and of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective Affiliates, employees or agents) shall be commenced
exclusively in the state or federal courts sitting in, or having jurisdiction over, New Castle County in the State of Delaware (the “Delaware Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of
the Delaware Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of the any of the Transaction Documents), and
hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any such Delaware Court, or that such Proceeding has been commenced in an improper or inconvenient forum. Each
party hereto hereby irrevocably waives personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party
at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any manner permitted by law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the
transactions contemplated hereby. If either party shall commence a Proceeding to enforce any provisions of a Transaction Document, then the prevailing party in such Proceeding shall be reimbursed by the other party for its reasonable attorneys’
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Proceeding. 
 Section
7.10. Survival. The representations, warranties, agreements and covenants contained herein shall survive the Closing and the delivery of the Securities; provided, however, that the representations and warranties shall expire one month
after the Company files its 10-K for the period ending December 31, 2008. 

  
 33 









 Section 7.11. Execution. This Agreement may be executed in two or more
counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need
not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same
force and effect as if such facsimile signature page were an original thereof, notwithstanding any subsequent failure or refusal of the signatory to deliver an original executed in ink. 

Section 7.12. Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the
validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute
therefor, and upon so agreeing, shall incorporate such substitute provision in this Agreement. 
 Section 7.13.
Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation
thereof, or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction and customary and reasonable indemnity, if requested. The
applicants for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement Securities. If a replacement certificate or instrument evidencing any Securities
is requested due to a mutilation thereof, the Company may require delivery of such mutilated certificate or instrument as a condition precedent to any issuance of a replacement. 

Section 7.14. Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including
recovery of damages, each of the Investors and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that, except as expressly set forth herein with respect to liquidated damages, monetary damages
may not be adequate compensation for any loss incurred by reason of any breach of obligations described in the foregoing sentence and hereby agrees to waive in any action for specific performance of any such obligation the defense that a remedy at
law would be adequate. 
 Section 7.15. Independent Nature of Investors’ Obligations and Rights. The
obligations of each Investor under any Transaction Document are several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under any
Transaction Document. The decision of each Investor to purchase Securities pursuant to the Transaction Documents has been made by such Investor independently of any other Investor. Nothing contained herein or in any Transaction Document, and no
action taken by any Investor pursuant thereto, shall be deemed to constitute the Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert or
as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Investor acknowledges that no other Investor has acted as agent for such Investor in connection with making its investment hereunder and
that no Investor will be acting as agent of 

  
 34 









 
such Investor in connection with monitoring its investment in the Securities or enforcing its rights under the Transaction Documents. Each Investor shall be entitled to independently protect and
enforce its rights, including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for
such purpose. The Company acknowledges that each of the Investors has been provided with the same Transaction Documents for the purpose of closing a transaction with multiple Investors and not because it was required or requested to do so by any
Investor. 
 [Signatures are on following pages.] 

  
 35 









 IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be
duly executed by their respective authorized signatories as of the date first indicated above. 
  

			
	 COMPANY

	
	 ENERGY FOCUS, INC.

		
	 By:
	 	 
	 Name: 
	 	 
	 Title:
	 	 
	
	 [Instructions to PURCHASER:

	
	Fill in the blank lines below, sign, and follow the below wire transfer instructions to send your purchase price.]
	
	
PURCHASER:                     
                                         
 

	
                        
                (name of purchaser)

		
	 By:
	 	 
	 Name:
	 	 
	 Title:
	 	 
	
	
Aggregate Purchase Price: $                 
                          

	
	
Number of Units Purchased:                 
                           

	
	 Name of Holder (if different from above):

	
	 
	
	 Shares: Certificated              [or] Book Entry
            

	
	
Tax ID No.:                    
                                         
                 




  
 Signature Page









 
					
	 Address for Notice:

	
	 
	
	 
	
	 
		
	 Telephone No.:
	 	 
	 Facsimile No.:
	 	 
	 E-mail Address:
	 	 
	 Attention:
	 	 
	
	 Delivery Instructions (if different from above):

	 c/o
	 	 
	 Street: 
	 	 
	 City/State/Zip:
	 	 
	 Attention:
	 	 
	 Telephone No.:
	 	 



  
 Signature Page









 EXHIBIT A 
 List of Purchasers, Addresses and Number of Units Purchased 

  
 i 








 EXHIBIT B 
 Form of Warrant 

  
 ii 









 EXHIBIT C 
 Form of Legal Opinion 

  
 iii









 February [24], 2012 
 To the Investors 
 Listed on Exhibit A to this Letter 

 

	 	Re:	Securities Purchase Agreement dated as of February [24], 2012 among Energy Focus, Inc. and the Investors listed on the signature pages of the Agreement


 Ladies and Gentlemen: 
 We have acted as counsel to Energy Focus, Inc., a Delaware corporation (the “Company”), in connection with the Securities Purchase Agreement, dated as of February [24], 2012 among you and the
Company (the “Agreement”). Our engagement has been limited to specific matters on which we have been consulted by the Company, and there may be matters pertaining to the Company of which we have no knowledge. 

Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Agreement.

 In connection with this opinion, we have examined originals or copies of the following documents: (i) the Certificate of
Incorporation of the Company, together with all amendments thereto, as certified by the Secretary of the State of Delaware on February [            ], 2012 (the “Charter”);
(ii) the Bylaws of the Company, as certified by the Secretary of the Company on February [            ], 2012 (the “Bylaws”); (iii) the Certificate, dated February
[            ], 2012, of the Secretary of State of the State of Delaware regarding the legal existence and corporate good standing of the Company; (iv) the Agreement; and (v) the
form of Warrant. We have also examined such other records, agreements and instruments of the Company, certificates of public officials and officers of the Company, and such other documents and records and such matters of law as we have deemed
appropriate as a basis for the opinions hereinafter expressed. In making such examinations, we have assumed, without independent verification, the genuineness of all signatures (other than those of the Company), the legal capacity of natural
persons, the authenticity of all documents submitted to us as originals and the conformity to the originals of all documents submitted to us as copies. With respect to the legal existence and good standing of the Company, we have relied solely on
the Certificate issued by the Secretary of State of the State of Delaware referenced above. As to various facts material to the opinions set forth herein, we have relied without independent verification upon factual representations made by you and
the Company in the Agreement, upon certificates of public officials and upon facts certified to us in writing by officers of the Company. 
 For purposes of the opinions expressed herein, we have assumed that at all relevant times you had all requisite power and authority and had taken all necessary action to enter into and perform all of your
obligations under the Agreement and that the Agreement was and will continue to be your valid, binding and enforceable obligation. You have not asked us to express, and we do not express, any opinion concerning the application of any federal, state
or local statute, law, rule or regulation to your authority to enter into and to carry out your obligations, or to exercise your rights, under the Agreement. 

  
 C-1









 This opinion is limited to the Delaware General Corporation Law (the DGCL”) and the
federal laws of the United States of America, and we express no opinions with respect to the law of any other jurisdiction. We are not admitted to practice law in the State of Delaware and we do not hold ourselves out as experts in the laws of the
State of Delaware other than the DGCL. For purposes of this opinion, we have, with your consent, assumed that the substantive and procedural provisions of the laws of the State of Delaware (other than the DGCL) which govern the Transaction Documents
are identical to those of the State of Ohio. 
 Based upon and subject to the foregoing and subject also to the general
qualifications stated following paragraph number 8 below, we hereby advise you that, in our opinion, as of the date hereof: 
 1.
The Company is a corporation validly existing and in good standing under the DGCL, and has all corporate power and authority necessary to own its properties and to conduct its business as described in the SEC Reports. 

2. The Company has the requisite corporate power and authority to execute, deliver and perform its obligations under the Transaction
Documents. 
 3. The execution and delivery of the Transaction Documents by the Company and the consummation by the Company of
the transactions contemplated thereby have been duly authorized by the Company’s Board of Directors and no further consent or authorization of the Company, its Board of Directors, or its stockholders is required. 

4. The execution, delivery and performance of, and compliance by the Company with the terms of, the Transaction Documents, the issuance
of the Shares and the Warrants pursuant thereto, and the issuance of the Warrant Shares upon exercise of the Warrants in accordance with their terms, do not, and will not, violate (i) any provision of the Charter or the Bylaws or (ii) any
provision of the DGCL. 
 5. The Transaction Documents have been duly executed and delivered by the Company and constitute the
valid and binding obligations of the Company enforceable against the Company in accordance with their respective terms, subject to the limitation that the indemnification and contribution provisions of Article 4 of the Agreement may be unenforceable
as a matter of public policy. 
 6. The Warrant Shares, when issued and paid for upon exercise of the Warrants in accordance
with their terms, will be duly authorized, validly issued, fully paid and nonassessable shares of Common Stock. 
 7. Based in
part upon your representations and warranties made in Section 3.2 of the Agreement, the Securities may be issued to you without registration under the Securities Act. 

  
 C-2









 8. No consent, approval or authorization of, or designation, declaration or filing with, any
governmental entity or agency is required on the part of the Company as a condition to the offer, sale or issuance of the Securities or the Company’s valid execution, delivery and performance of its obligations under the Transaction Documents.

 Our opinions set forth above are subject to the following general qualifications: 

a. The validity and enforceability of any obligation and the exercise of rights and remedies may be limited by (i) bankruptcy,
insolvency, reorganization, fraudulent conveyance, moratorium or other similar laws affecting the enforcement generally of the rights and remedies of creditors or the obligations of debtors, and (ii) general principles of equity (regardless of
whether such enforcement is considered in a proceeding at law or in equity), including, without limitation, the discretion of any court of competent jurisdiction in granting specific performance or injunctive or other equitable relief. 

b. The enforcement of any rights or remedies is or may be subject to an implied duty on the part of the party seeking to enforce such
rights to take action and make determinations on a reasonable basis and in good faith. 
 c. The enforceability of the
Transaction Documents may be limited by general principles of contract law which include (i) the unenforceability of provisions requiring that amendments or waivers be in writing, to the extent that an oral agreement modifying such provisions
has been entered into, and (ii) the general rule that, when less than all of an agreement is enforceable, the balance of such agreement is enforceable only when the unenforceable portion is not an essential part of the bargain expressed by the
agreement. 
 d. We express no opinion with respect to the choice of law provisions contained in the Transaction Documents.

 These opinions are limited to the matters expressly stated herein, are rendered solely for your benefit and may not be quoted
or relied upon for any other purpose or by an other person. This opinion is given as of the date hereof and we assume no obligation to update or supplement this opinion to reflect any facts or circumstances which may hereafter come to our attention
or any changes in laws which may hereafter occur. 
 Very truly yours, 

Cowden & Humphrey Co. LPA 

  
 C-3









 EXHIBIT D 
 Plan of Distribution 
 The selling stockholders, which as used herein
includes donees, pledgees, transferees or other successors-in-interest selling shares of common stock or interests in shares of common stock received after the date of this prospectus from a selling stockholder as a gift, pledge, partnership
distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their shares of common stock or interests in shares of common stock on any stock exchange, market or trading facility on which the shares
are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated
prices. 
 The selling stockholders may use any one or more of the following methods when disposing of shares or interests
therein: 
  

	 	•	 	 ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; 



 

	 	•	 	 block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to
facilitate the transaction; 


  

	 	•	 	 purchases by a broker-dealer as principal and resale by the broker-dealer for its account; 



 

	 	•	 	 an exchange distribution in accordance with the rules of the applicable exchange; 



 

	 	•	 	 privately negotiated transactions; 


  

	 	•	 	 short sales effected after the date the registration statement of which this Prospectus is a part is declared effective by the SEC;



  

	 	•	 	 through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;



  

	 	•	 	 broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share; and



  

	 	•	 	 a combination of any such methods of sale. 


 The selling stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured
obligations, the pledgees or secured parties may offer and sell the shares of common stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act
amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer the shares of common stock in other circumstances,
in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus. 

  
 D-1









 In connection with the sale of our common stock or interests therein, the selling
stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume. The selling stockholders may also
sell shares of our common stock short and deliver these securities to close out their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus,
which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). 
 The aggregate proceeds to the selling stockholders from the sale of the common stock offered by them will be the purchase price of the common stock less discounts or commissions, if any. Each of the
selling stockholders reserves the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly or through agents. We will not receive any of the proceeds
from this offering. Upon any exercise of the warrants by payment of cash, however, we will receive the exercise price of the warrants. 
 The selling stockholders also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act of 1933, provided that they meet the criteria and
conform to the requirements of that rule, or in private transactions under Section 4 of the Securities Act of 1933, provided that they meet the requirements for sales under that Section. 

The selling stockholders and any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests
therein may be “underwriters” within the meaning of Section 2(11) of the Securities Act. Any discounts, commissions, concessions or profit they earn on any resale of the shares may be underwriting discounts and commissions under the
Securities Act. Selling stockholders who are “underwriters” within the meaning of Section 2(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act. 

To the extent required, the shares of our common stock to be sold, the names of the selling stockholders, the respective purchase prices
and public offering prices, the names of any agents, dealer or underwriter, any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective
amendment to the registration statement that includes this prospectus. 
 In order to comply with the securities laws of some
states, if applicable, the common stock may be sold in these jurisdictions only through registered or licensed brokers or dealers. In addition, in some states the common stock may not be sold unless it has been registered or qualified for sale or an
exemption from registration or qualification requirements is available and is complied with. 

  
 D-2









 We have advised the selling stockholders that the anti-manipulation rules of Regulation M
under the Exchange Act may apply to sales of shares in the market and to the activities of the selling stockholders and their affiliates. In addition, to the extent applicable we will make copies of this prospectus (as it may be supplemented or
amended from time to time) available to the selling stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer that participates in transactions
involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act. 
 We have
agreed to indemnify the selling stockholders against liabilities, including liabilities under the Securities Act and state securities laws, relating to the registration of the shares offered by this prospectus. 

We have agreed with the selling stockholders to keep the registration statement of which this prospectus constitutes a part effective
until the earlier of (1) such time as all of the shares covered by this prospectus have been disposed of pursuant to and in accordance with the registration statement or (2) the date on which the shares may be sold without restriction
pursuant to Rule 144 of the Securities Act. 

  
 D-3